BC-DXI-843是一种 AIMP2-DX2 抑制剂,其 IC50 值为 0.92 μM。在 H460 细胞的肿瘤异种移植小鼠模型中(50 mg/kg 剂量)显示了体内疗效。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | AIMP2-DX2, a splicing variant of AIMP2, is up-regulated in lung cancer, possesses oncogenic activity, and results in tumorigenesis. BC-DXI-843 is a potent and selective AIMP2-DX2 inhibitor with an IC50 value of 0.92 μM which is more than 100-fold selectivity over AIMP2 (IC50 >100 μM) in a luciferase assay. In H460 cells, BC-DXI-843 exhibited dose-dependent inhibition of DX2 protein levels, and it efficiently induced degradation of DX2 at a very low concentration of 1.20 μM. Moreover, BC-DXI-843 demonstrated in vivo efficacy in a tumor xenograft mouse model (H460 cells) at a dosage of 50 mg/kg, suggesting it as a promising lead for development of novel therapeutics targeting AIMP2-DX2 in lung cancer[1]. |
作用机制 | BC-DXI-843 was positioned very close to L80, T82, F116, T117, and K129 and it forms two hydrogen bonds with the hydrophobic pocket via T82 and D52[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.83mL 0.37mL 0.18mL |
9.15mL 1.83mL 0.91mL |
18.29mL 3.66mL 1.83mL |
CAS号 | 2421117-98-6 |
分子式 | C28H26N4O4S2 |
分子量 | 546.66 |
别名 | |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place,Inert atmosphere,Room temperature |
溶解方案 |
DMSO: 250 mg/mL(457.32 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |